Authors
Latest:
Succession Attack Plan: Get Strategic with Your Critical RolesOutlining four considerations for biopharma companies in ensuring that their approach to replacing and filling key leadership positions is more truly aligned with future goals in business delivery and risk management.
Latest:
From Potential to Value: Carving a Slice of the CGT ‘PIE'The importance of pre-approval information exchange (PIE) with payers and other strategic considerations to help navigate today’s market access challenges and regulatory requirements in bringing promising cell and gene therapies to the market.
Latest:
This is Your Wake-Up Call–Sunshine Act Enforcement is HereMitigating potential risk for stakeholders in light of latest Sunshine Act developments.
Latest:
The Importance of Opinion Leader-Content in a Digital TransformationMarketers are working to reimagine how they leverage key opinion leader (KOL) support during COVID-19.
Latest:
Identifying Healthcare Trends from Conversation DataHealthcare customers and patients are facing more avenues to receive misinformation about drugs than ever before.
Latest:
Evolving Client/Agency Model Beyond Just a Menu of CapabilitiesAre you working with a network or a committee?
Latest:
Talent Management Strategies for Post-Milestone GrowthInsights from Takeda, Jazz, Nestlé Health Sciences, Humana, and other healthcare executives
Latest:
The Shifting Pharmacy Landscape in 2025Polypharmacy, biosimilars, and GLP-1s among the evolving trends likely to play out in the pharmacy benefits space.
Latest:
Developing Patient-Focused Solutions: How a Multi-Modality Approach to Drug Discovery and Development is Driving Transformative InnovationWhen considering factors like disease biology and patient needs in drug discovery and development, the goal is to deliver effective and scalable treatments globally by balancing established approaches like small molecules or protein therapeutics with more complex modalities such as RNA, cell, and gene therapies.
Latest:
3 ASCO Insights for Pharma CommunicatorsThe world’s largest cancer research meeting, the American Society of Clinical Oncology (ASCO) Annual Meeting, recently convened in person in Chicago after two years of being held virtually. Sara Baker and Kristine Austria Fan of Marina Maher Communications provide their takeaways from the meeting.
Latest:
'Faster, Please': Key Challenges in Chemicals and Materials R&DCompanies must address myriad challenges to improve upon issues such as data quality and transparency, process efficiency, and artificial intelligence/machine learning preparedness.
Latest:
The Complementary Role of Real-World Evidence and Clinical Trials in Addressing Unmet Needs for IBD PatientsPatients with Crohn's disease and ulcerative colitis face a high disease burden.
Latest:
Omnichannel Marketing Challenges for European Life Sciences Companies: A Data Science PerspectiveAs EU brand leaders build their omnichannel customer engagement strategies, they need to address challenges in the European environment with a well-thought-out deployment plan.
Latest:
How Technology Can be Used to Improve AdherenceComprehensive dosage monitoring of topical treatments for mild to moderate psoriasis.
Latest:
Social Determinants of Health Data Evolution: Improve Access, Adherence and Achieve More Equitable OutcomesWebinar Date/Time: Tue, May 16, 2023 2:00 PM EDT
Latest:
A Pricing Revolution: The State OffensiveThe second of two articles summarizing the broad range of government efforts to control drug pricing focuses on state government efforts.
Latest:
Real-World Evidence Is Becoming a Pivotal Component in Chinese HealthcareIts use enables key processes such as early access, regulatory approval, and reimbursement listing.
Latest:
PREP Act Protections for COVID-19 Vaccine LiabilityHow PREP Act protections will apply to potential COVID-19 vaccine-related claims.
Latest:
Commercial Models for the Changing Life Sciences MarketLife sciences companies have an opportunity to craft a sales approach that resonates with clients, protects against future disruptions and stands out from the competition.
Latest:
Copay Adjustment Chess Match: What Will Payers Do Next?As new litigation looms in the debate over use of copay accumulator programs, a look at potential next moves for payers—and steps drug manufacturers should take to ward off cost-driven non-adherence.
Latest:
Digital Engagement is Only as Good as the First-Party Data It ProvidesFirst-party insights bridge marketing and sales to deliver better HCP experiences.
Latest:
Precision Medicine: Investments and Outcomes ExpectedPrecision medicine is now seen as a healthcare approach for both the present and the future, particularly with the explosion of personalized care delivery.
Latest:
AI’s Promise in Delivering on Patient-CentricityHow pharmaceutical companies can utilize AI at key stages of the treatment journey to enhance patient-centric engagement by increasing empathy and humanity in patient interactions.
